151 related articles for article (PubMed ID: 33110268)
1. Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomalies.
Li C; Vandersluis S; Holubowich C; Ungar WJ; Goh ES; Boycott KM; Sikich N; Dhalla I; Ng V
Genet Med; 2021 Mar; 23(3):451-460. PubMed ID: 33110268
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
[TBL] [Abstract][Full Text] [Related]
3. Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from Canada.
Regier DA; Loewen R; Chan B; Ehman M; Pollard S; Friedman JM; Stockler-Ipsiroglu S; van Karnebeek C; Race S; Elliott AM; Dragojlovic N; Lynd LD; Weymann D
Genet Med; 2024 Apr; 26(4):101069. PubMed ID: 38205742
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions.
Lavelle TA; Feng X; Keisler M; Cohen JT; Neumann PJ; Prichard D; Schroeder BE; Salyakina D; Espinal PS; Weidner SB; Maron JL
Genet Med; 2022 Jun; 24(6):1349-1361. PubMed ID: 35396982
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum Disorder.
Yuen T; Carter MT; Szatmari P; Ungar WJ
Appl Health Econ Health Policy; 2018 Aug; 16(4):481-493. PubMed ID: 29651777
[TBL] [Abstract][Full Text] [Related]
6. Cost Effectiveness of Karyotyping, Chromosomal Microarray Analysis, and Targeted Next-Generation Sequencing of Patients with Unexplained Global Developmental Delay or Intellectual Disability.
Li Y; Anderson LA; Ginns EI; Devlin JJ
Mol Diagn Ther; 2018 Feb; 22(1):129-138. PubMed ID: 29209992
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Sequencing Modalities for Children with Unexplained Global Developmental Delay and Intellectual Disabilities-A Narrative Review.
Ko MH; Chen HJ
Children (Basel); 2023 Mar; 10(3):. PubMed ID: 36980059
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive iterative approach is highly effective in diagnosing individuals who are exome negative.
Shashi V; Schoch K; Spillmann R; Cope H; Tan QK; Walley N; Pena L; McConkie-Rosell A; Jiang YH; Stong N; Need AC; Goldstein DB;
Genet Med; 2019 Jan; 21(1):161-172. PubMed ID: 29907797
[TBL] [Abstract][Full Text] [Related]
9. Exome Sequencing for Prenatal Detection of Genetic Abnormalities in Fetal Ultrasound Anomalies: An Economic Evaluation.
Kodabuckus SS; Quinlan-Jones E; McMullan DJ; Maher ER; Hurles ME; Barton PM; Kilby MD
Fetal Diagn Ther; 2020; 47(7):554-564. PubMed ID: 31962312
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods.
Ferket BS; Baldwin Z; Murali P; Pai A; Mittendorf KF; Russell HV; Chen F; Lynch FL; Lich KH; Hindorff LA; Savich R; Slavotinek A; Smith HS; Gelb BD; Veenstra DL
Genet Med; 2022 Oct; 24(10):2014-2027. PubMed ID: 35833928
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders.
Nurchis MC; Radio FC; Salmasi L; Heidar Alizadeh A; Raspolini GM; Altamura G; Tartaglia M; Dallapiccola B; Pizzo E; Gianino MM; Damiani G
JAMA Netw Open; 2024 Jan; 7(1):e2353514. PubMed ID: 38277144
[TBL] [Abstract][Full Text] [Related]
12. Genome sequencing demonstrates high diagnostic yield in children with undiagnosed global developmental delay/intellectual disability: A prospective study.
Sun Y; Peng J; Liang D; Ye X; Xu N; Chen L; Yan D; Zhang H; Xiao B; Qiu W; Shen Y; Pang N; Liu Y; Liang C; Qin Z; Luo J; Chen F; Wang J; Zhang Z; Wei H; Du J; Yan H; Duan R; Wang J; Zhang Y; Liao S; Sun K; Wu L; Yu Y
Hum Mutat; 2022 May; 43(5):568-581. PubMed ID: 35143101
[TBL] [Abstract][Full Text] [Related]
13. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).
Manickam K; McClain MR; Demmer LA; Biswas S; Kearney HM; Malinowski J; Massingham LJ; Miller D; Yu TW; Hisama FM;
Genet Med; 2021 Nov; 23(11):2029-2037. PubMed ID: 34211152
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.
Srivastava S; Love-Nichols JA; Dies KA; Ledbetter DH; Martin CL; Chung WK; Firth HV; Frazier T; Hansen RL; Prock L; Brunner H; Hoang N; Scherer SW; Sahin M; Miller DT;
Genet Med; 2019 Nov; 21(11):2413-2421. PubMed ID: 31182824
[TBL] [Abstract][Full Text] [Related]
15. Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness.
Palmer EE; Schofield D; Shrestha R; Kandula T; Macintosh R; Lawson JA; Andrews I; Sampaio H; Johnson AM; Farrar MA; Cardamone M; Mowat D; Elakis G; Lo W; Zhu Y; Ying K; Morris P; Tao J; Dias KR; Buckley M; Dinger ME; Cowley MJ; Roscioli T; Kirk EP; Bye A; Sachdev RK
Mol Genet Genomic Med; 2018 Mar; 6(2):186-199. PubMed ID: 29314763
[TBL] [Abstract][Full Text] [Related]
16. Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2022; 22(3):1-155. PubMed ID: 36158868
[TBL] [Abstract][Full Text] [Related]
17. An efficient genetic test flow for multiple congenital anomalies and intellectual disability.
Yokoi T; Enomoto Y; Tsurusaki Y; Harada N; Saito T; Nagai JI; Naruto T; Kurosawa K
Pediatr Int; 2020 May; 62(5):556-561. PubMed ID: 31955471
[TBL] [Abstract][Full Text] [Related]
18. A single center experience with publicly funded clinical exome sequencing for neurodevelopmental disorders or multiple congenital anomalies.
Pode-Shakked B; Barel O; Singer A; Regev M; Poran H; Eliyahu A; Finezilber Y; Segev M; Berkenstadt M; Yonath H; Reznik-Wolf H; Gazit Y; Chorin O; Heimer G; Gabis LV; Tzadok M; Nissenkorn A; Bar-Yosef O; Zohar-Dayan E; Ben-Zeev B; Mor N; Kol N; Nayshool O; Shimshoviz N; Bar-Joseph I; Marek-Yagel D; Javasky E; Einy R; Gal M; Grinshpun-Cohen J; Shohat M; Dominissini D; Raas-Rothschild A; Rechavi G; Pras E; Greenbaum L
Sci Rep; 2021 Sep; 11(1):19099. PubMed ID: 34580403
[TBL] [Abstract][Full Text] [Related]
19. The cost and diagnostic yield of exome sequencing for children with suspected genetic disorders: a benchmarking study.
Dragojlovic N; Elliott AM; Adam S; van Karnebeek C; Lehman A; Mwenifumbo JC; Nelson TN; du Souich C; Friedman JM; Lynd LD
Genet Med; 2018 Sep; 20(9):1013-1021. PubMed ID: 29300375
[TBL] [Abstract][Full Text] [Related]
20. Clinical exome sequencing as the first-tier test for diagnosing developmental disorders covering both CNV and SNV: a Chinese cohort.
Dong X; Liu B; Yang L; Wang H; Wu B; Liu R; Chen H; Chen X; Yu S; Chen B; Wang S; Xu X; Zhou W; Lu Y
J Med Genet; 2020 Aug; 57(8):558-566. PubMed ID: 32005694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
